S.Biomedics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	447,103	453,470	203,202	130,376	-	-
Market Cap Growth	64.78%	123.16%	55.86%	-	-	-
Enterprise Value	452,696	456,739	206,789	133,226	-	-
Last Close Price	36100.00	37950.00	17300.00	11500.00	-	-
PS Ratio	27.02	27.40	14.80	9.95	-	-
PB Ratio	26.73	27.11	11.10	10.55	-	-
P/TBV Ratio	53.55	54.31	17.74	18.92	-	-
EV/Sales Ratio	27.36	27.60	15.06	10.16	-	-
Debt / Equity Ratio	0.73	0.73	1.03	0.97	13.33	1.78
Net Debt / Equity Ratio	-0.15	-0.15	-0.28	0.11	6.16	-1.58
Net Debt / EBITDA Ratio	0.39	0.39	1.39	-0.30	-2.85	1.91
Net Debt / FCF Ratio	0.29	0.29	1.06	-0.17	-0.51	1.61
Asset Turnover	0.39	0.39	0.36	0.47	0.57	0.50
Inventory Turnover	4.26	4.26	2.99	3.33	5.14	6.18
Quick Ratio	1.33	1.33	2.20	1.67	0.75	3.19
Current Ratio	1.61	1.61	2.49	2.05	0.95	3.44
Return on Equity (ROE)	-40.30%	-40.30%	-37.96%	-138.29%	-195.41%	-121.47%
Return on Assets (ROA)	-12.15%	-12.15%	-8.89%	-13.30%	-11.13%	-16.13%
Return on Capital Employed (ROCE)	-28.90%	-28.90%	-16.60%	-24.70%	-30.00%	-34.00%
Earnings Yield	-1.82%	-1.79%	-3.29%	-7.92%	-	-
FCF Yield	-1.92%	-1.89%	-2.41%	-6.13%	-	-
Buyback Yield / Dilution	-3.22%	-3.22%	-5.22%	-6.97%	-0.67%	-0.42%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.